Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002529935 | SCV000760677 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358807 | SCV002621656 | uncertain significance | Cardiovascular phenotype | 2023-11-13 | criteria provided, single submitter | clinical testing | The p.S1279T variant (also known as c.3836G>C), located in coding exon 31 of the RYR2 gene, results from a G to C substitution at nucleotide position 3836. The serine at codon 1279 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV003328611 | SCV004035369 | uncertain significance | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Not located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009) |